Trials / Unknown
UnknownNCT02624297
Chemoreflex Control of Sympathetic Activity in Patients With Coronary Artery Disease
Effect of Exercise Training on Chemoreflex Control of Sympathetic Activity in Patients With Coronary Artery Disease and Obstructive Sleep Apnea
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University of Sao Paulo General Hospital · Academic / Other
- Sex
- All
- Age
- 35 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The investigators hypothesize that chemoreflex response of muscle sympathetic nerve activity (MSNA) during hypoxia and hypercapnia will be increased in coronary artery disease (CAD) patients and that the presence of obstructive sleep apnea (OSA) will potentiate these responses. And, that the exercise training would decrease the chemoreflex response of MSNA in these patients.
Detailed description
Forty patients with coronary artery disease, with (n=20) and without (n=20) obstructive sleep apnea will be studied. A healthy control, age-paired group (n=10) will be also evaluated. The patients will be submitted to a polysomnography and randomized for clinical follow-up or exercise training for four months. It will evaluated the autonomic function, chemoreflex control of sympathetic activity during hypoxic and hypercapnic maneuvers, endothelial function and inflammatory markers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aerobic exercise training | The patients will be submitted to four months of aerobic exercise training, three time a week. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2017-12-01
- Completion
- 2020-01-01
- First posted
- 2015-12-08
- Last updated
- 2017-05-16
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02624297. Inclusion in this directory is not an endorsement.